<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Adv Biomed Res</journal-id><journal-id journal-id-type="iso-abbrev">Adv Biomed Res</journal-id><journal-id journal-id-type="publisher-id">ABR</journal-id><journal-title-group><journal-title>Advanced Biomedical Research</journal-title></journal-title-group><issn pub-type="epub">2277-9175</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25878996</article-id><article-id pub-id-type="pmc">4386208</article-id><article-id pub-id-type="publisher-id">ABR-4-71</article-id><article-id pub-id-type="doi">10.4103/2277-9175.153895</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>A histomorphometric study of the effect of doxycycline and erythromycin on bone formation in dental alveolar socket of rat</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shahabooei</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Razavi</surname><given-names>Sayed Mohammad</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Minaiyan</surname><given-names>Mohsen</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Birang</surname><given-names>Reza</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Behfarnia</surname><given-names>Parichehr</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Yaghini</surname><given-names>Jaber</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Naghsh</surname><given-names>Narges</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Ghalayani</surname><given-names>Parichehr</given-names></name><xref ref-type="aff" rid="aff4">3</xref></contrib><contrib contrib-type="author"><name><surname>Hajisadeghi</surname><given-names>Samira</given-names></name><xref ref-type="aff" rid="aff5">4</xref></contrib></contrib-group><aff id="aff1">Department of Periodontology, Torabinejad Dental Research Center, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="aff2"><label>1</label>Department of Oral and Maxillofacial Pathology, Torabinejad Dental Research Center, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="aff3"><label>2</label>Department of Pharmacology, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="aff4"><label>3</label>Department of Oral and Maxillofacial Medicine, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="aff5"><label>4</label>Department of Oral and Maxillofacial Medicine, School of Dentistry, Qom University of Medical Sciences, Qom, Iran</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Narges Naghsh, Department of Periodontology, Isfahan University of Medical Sciences, Isfahan, Iran. E-mail: <email xlink:href="n_naghsh@dnt.mui.ac.ir">n_naghsh@dnt.mui.ac.ir</email></corresp></author-notes><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>25</day><month>3</month><year>2015</year></pub-date><volume>4</volume><elocation-id>71</elocation-id><history><date date-type="received"><day>14</day><month>9</month><year>2013</year></date><date date-type="accepted"><day>01</day><month>6</month><year>2014</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2015 Shahabooei.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>The aim of the present study was to evaluate whether subantimicrobial doses of doxycycline (DOX) and erythromycin (EM) used for the treatment of peri-implant osteolysis due to their anti-osteoclastogenesis can interfere with the osseous wound healing process in rat alveolar socket.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>Forty-five male Wistar rats had their first maxillary right molar extracted and were divided into three groups. DOX and EM at the doses of 5 mg/kg/day orally (p.o.) and 2 mg/kg/day intraperitoneally (i.p.) were administered respectively to two separate groups for 7 days after operation. In the control group the animals received normal saline (5 ml/kg). Five rats were sacrificed at 7, 14 and 21 days post-extraction in each study group. A histomorphometric analysis was used to evaluate new bone formation inside the alveolar socket. Significant level was set at 0.05.</p></sec><sec id="st3"><title>Results:</title><p>The findings showed that the percentage of new bone formation (NBF) enhanced significantly on days 7 and 14. There was no significant difference in the NBF between DOX and EM groups.</p></sec><sec id="st4"><title>Conclusion:</title><p>Short-term treatment with both DOX and EM enhanced new bone formation without any advances in favor of each drug.</p></sec></abstract><kwd-group><kwd>Doxycycline</kwd><kwd>erythromycin</kwd><kwd>histomorphometry</kwd><kwd>osteogenesis</kwd><kwd>rats</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Following tooth extraction, the healing process of the empty socket begins with the formation of woven bone which ultimately remodels and restores the defect.[<xref rid="ref1" ref-type="bibr">1</xref>] Many factors can influence and enhance or even delay the process of bone healing. These factors include: Type of tissue, location and condition of wound, its vascular supply, microbial condition and local and systemic factors.[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref>] Systemic factors such as cytokines, hormones, adhesion molecules and growth factors can regulate the proliferation, differentiation, function and survival of bone cells.[<xref rid="ref4" ref-type="bibr">4</xref>] The formation and remodeling of bone structures result from coupling subsequent deposition of bone matrix by osteoblasts which balances bone resorption by activated osteoclast.[<xref rid="ref5" ref-type="bibr">5</xref>]</p><p>Chemically modified tetracyclines (CMTs) are derivatives of tetracycline group of drugs which lack antimicrobial action and have significant effect on bone cells <italic>in vitro</italic> and <italic>in vivo</italic>. Literatures describing the effects of tetracyclines (TCs) in osteoblasts are limited, but recent reports suggest that some TCs may have an anabolic effect in bone.[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref>] In a recent study, Williams <italic>et al</italic>. reported that minocycline moderately increased bone mineral density in old ovariectomized (OVX) rats characterized by a two-fold induced bone formation rate. The authors concluded that the overall effect was likely to be due to an increase in bone formation coupled with a decrease in bone resorption.[<xref rid="ref8" ref-type="bibr">8</xref>] Others have reported that TCs can increase bone formation in diabetic and OVX rats.[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref>]</p><p>Doxycycline (DOX) belongs to CMT family antibiotics. Recently, it has been reported that DOX was able to inhibit <italic>in vitro</italic> osteoclastogenesis and cause apoptosis of mature osteoclasts caused bone resorption. These effects extend beyond the mere inhibition of matrix metalloproteinase (MMP).[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref13" ref-type="bibr">13</xref>] Erythromycin (EM), a 14-membered lactone ring macrolide antibiotic, has attracted recently clinical attention because of its anti-inflammatory effects that are independent of its antimicrobial action.[<xref rid="ref14" ref-type="bibr">14</xref><xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref>] In a previous <italic>in vitro</italic> study, it was demonstrated that EM significantly inhibited mRNA expression of NF-kB, cathepsin k (CPk), IL-1B, and TNF-&#x003b1; in wear debris-activated mouse RAW-264.7 macrophage cell line, associated with the reduction of NF-kB DNA-binding activity.[<xref rid="ref17" ref-type="bibr">17</xref>] In another study in the orthopedic area, it was demonstrated that periprosthetic EM delivery reduced regional inflammation and improved the quality of surrounding bone.[<xref rid="ref18" ref-type="bibr">18</xref>]</p><p>As there is no comparative clinical study about bone formation potential of these two antibiotics, the purpose of the present study was to compare the effect of subantimicrobial doses of DOX and EM on the amount of new bone formation by histomophometric analysis following tooth extraction, a common dental surgical procedure, in rats.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><p>Forty-five male Wistar rats (8-10 weeks old at the beginning of the study) with an average body weight of (200 &#x000b1; 25g) were used in this study. All the procedures were conducted in accordance with ethics protocol of animal research that was approved by the institute for laboratory animals, Isfahan University of Medical Sciences. The animals were maintained in a collimate-controlled room (12 h light-12 h dark, 22 &#x000b1; 2<sup>&#x000b0;</sup> C) with free access to water and rat food pellets.</p><p>Rats randomly assigned to one of three following groups:</p><p>
<list list-type="order"><list-item><p>Control group: The rats underwent tooth extraction only and received normal saline (5 ml/kg, <italic>n</italic> = 15) by gavage.</p></list-item><list-item><p>Doxycycline group: The rats underwent tooth extraction and treated by DOX (5 mg/kg/day, orally by feeding tube for one week after operation, <italic>n</italic> = 15).[<xref rid="ref19" ref-type="bibr">19</xref>]</p></list-item><list-item><p>Erythromycin group: The rats underwent tooth extraction and treated by EM (2 mg/kg/day, intraperitoneally, for one week after operation <italic>n</italic> = 15).[<xref rid="ref18" ref-type="bibr">18</xref>]</p></list-item></list>
</p><p>The first maxillary right molar of all groups were carefully extracted under general anesthesia with intramuscular injection of a mixture of Ketamine 10% (Alfasan International, Woerden, Holland, 80 mg/kg) and xylasine (Neurotranq, Alfasan, Woerden, Holand, 8 mg/kg). No antibiotic or other medications were used. Treatment with test drugs were started at the day of tooth extraction and continued daily for 1 week.</p><p>All the rats were sacrificed at 1, 2 and 3 weeks after the operation (five rats in each interval in each group) with over dose ether inhalation. Then the rats maxillae were removed and dissected sagittally, so that the right sections of each animal was reserved and was stripped of musculature, cut cross-sectionally with a hand-held saw to isolate the region of the body with the extraction site.</p><sec id="sec2-1"><title>Histomorphometric evaluation</title><p>The samples were then fixed in a 4% paraformaldehyde solution, demineralized with 10% EDTA (Merck, Darmstadt, Germany) and embedded with paraffin (Merck, Darmstadt, Germany). The pieces were sectioned perpendicular to the long axis of the alveolar process with a microtom (Accu-Cut SRM, SAKURA, USA) in order to obtain slices with 5 &#x003bc;m thicknesses, which were mounted in previously poly-L-lysine slides and stained with hematoxylin and eosin (H&#x00026;E). For each sample five sections were prepared. The best section for each sample was selected for the histomorphometric analysis of the bone formation in the middle third of the rat alveolus.</p><p>The healing process, which in this phase consists of a gradual replacement of connective tissue by bone trabeculae, was estimated by new bone formation. In fact it is the newly formed bone around the circular environment of the socket.</p><p>For this purpose, five fields were analyzed in each histological section and examined by a light microscope (Olympus. CX21FS, Olympus Corporation, Tokyo, Japan) under 10 x objective lenses, then images were obtained with a digital camera (Canon powershot A650 IS; Tokyo, Japan.) and analyzed with Adobe Photoshop 7.0 (San Jose, CA) software. The percentage of newly formed bone rather than studied total area in each field was evaluated and the mean percentage was reported.</p></sec><sec id="sec2-2"><title>Statistical analysis</title><p>Statistical analysis was done by one-way ANOVA (analysis of variance) test, with the Tukey multiple comparisons test using SPSS version 20. Each value represents the mean &#x000b1; SEM. <italic>P</italic> &#x0003c; 0.05 was considered as significant difference for all comparisons.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><sec id="sec2-3"><title>Histomorphometric evaluation (New bone formation)</title><p>There was significant enhancement in percentage of new bone formation in the first and second weeks [<xref ref-type="table" rid="T1">Table 1</xref>]. The formation of new bone occurred in all groups.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>The mean percentage of new bone formation in dental socket of rats in experimental groups</p></caption><graphic xlink:href="ABR-4-71-g001"/></table-wrap><p>It has been shown that in the first week new bone formation was significantly higher in EM and DOX groups than the control group without any significant difference between two drug-treated groups, and in the second week DOX had significant increased bone formation than the control group without any difference in EM group than control or DOX groups. In the third week no meaningful difference was observed [<xref ref-type="fig" rid="F1">Figure 1</xref>].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Rat alveolar socket one and two weeks after tooth extraction (H and E, magnification &#x000d7; 100). The arrows show the area of new bone formation (NBF) in control, erythromycin and doxycycline groups</p></caption><graphic xlink:href="ABR-4-71-g002"/></fig></sec></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>Since EM is a safe drug with a less spectrum of action has lower side effects and is more tolerable than DOX,[<xref rid="ref20" ref-type="bibr">20</xref>] we designed this study to first evaluate bone healing effect after administration of these drugs in comparison with control, and secondly compare them to each other. To the best of our knowledge, no animal study has yet been conducted to report the effect of DOX and EM on bone formation after tooth extraction in rats.</p><p>Anti-osteoclastogenesis property of EM and DOX is independent of their anti-bacterial action,[<xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref>] so in this study we used subantimicrobial dose of each drug to eliminate the probability of developing resistant by pathologic and opportunistic bacterial species, for example the dosage used for EM is one quarter of that is needed for its anti-microbial effect.[<xref rid="ref17" ref-type="bibr">17</xref>]</p><p>In brief, immediately after tooth extraction, the socket is filled with blood clot, which is progressively invaded by fibroblasts originating from periodontal ligament remnants. Then the coagulum is gradually reabsorbed and an immature connective tissue is forming as a result of active proliferation of fibroblasts. So the amount of inflammatory cells and blood vessels decreases and the osteoblasts become evident as a differentiation of the young connective tissue. The osteoblasts are responsible for new bone production during socket healing. The alveolar bone neoformation takes place from the apical and lateral walls toward the center, and the healing process culminates with filling of the dental socket by trabecular bone.[<xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref22" ref-type="bibr">22</xref>]</p><p>It has been demonstrated that 14 days after tooth extraction in rats is a time in which maximal bone formation and alveolar volume occurs.[<xref rid="ref23" ref-type="bibr">23</xref>] It has been demonstrated that TCs are effective in preventing excessive angiogenesis and apoptosis and stimulating bone formation.[<xref rid="ref24" ref-type="bibr">24</xref>] In recent several literatures the effect of DOX and EM on RANKL (marker of bone resorption) and OPG (marker of bone formation) gene expression and the osteoclast and osteoblast cells was reported. Lee demonstrated that the presence of DOX in cultures derived from neonatal calvariae, a source of osteoblast precursors, or bone marrow-derived myeloid cells as a source of osteoclast precursors, resulted in increased OPG/RANKL ratio and Ren <italic>et al</italic>. showed that EM suppresses wear debris-induced osteoclastic bone resorption by, at least, down-regulation of the NF-kappa-B signaling pathway.[<xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref25" ref-type="bibr">25</xref>]</p><p>In an <italic>in vitro</italic> study with the aim of evaluation of bone physiologic metabolism, both DOX and minocycline increased significantly the proliferation of human bone marrow osteoblastic cells and their long-term use enhanced the number of active osteoblasts, that suggests a potential application in therapeutic approaches aiming to increase bone formation.[<xref rid="ref26" ref-type="bibr">26</xref>]</p><p>Ferraz and Mateus used nanohydroxyapatite microspheres as a delivery system for EM, amoxicillin and Augmentin to evaluate their interaction with osteoblasts. They concluded that EM induced osteoblastic cells proliferation higher than others, and also suggested the use of microsphere and EM as a good alternative carrier to enhance bone regeneration while treating periodontal defects.[<xref rid="ref27" ref-type="bibr">27</xref>]</p><p>On the other hand, Alakn <italic>et al</italic>. in a pilot study did not find any difference in newly formed bone in the tibial bone defects by administration of DOX in control rats that were injected with an equivalent volume of the vehicle (Citrate buffer) only.[<xref rid="ref28" ref-type="bibr">28</xref>] Olmarker <italic>et al</italic>. showed that 1 week administration of DOX (i.p., 3.0 mg/kg) after laminectomy in rats resulted in better bone healing.[<xref rid="ref29" ref-type="bibr">29</xref>] In another investigations by use of DOX after reflection of full thickness flap surgeries or following applying orthodontic forces bone loss reduced significantly.[<xref rid="ref30" ref-type="bibr">30</xref><xref rid="ref31" ref-type="bibr">31</xref>]</p><p>However, it seems to be possible that long-term administration of subantimicrobial doses of DOX and EM may delay healing due to lack of a resorption phase, for example prolonged use of both nonselective and selective NSAIDs (non-selective anti-inflammatory drugs) as anti-inflammatory and anti-osteoclastogenesis drugs can hinder reparational long bone formation in the orthopedic area.[<xref rid="ref32" ref-type="bibr">32</xref>]</p><p>The mechanisms for the observed findings have not been studied in detail. Since inflammation is critical for bone healing, the anti-inflammatory properties of DOX and EM may reduce the inflammatory response. Maybe this controversy is due to the balance between growth factors and inflammatory cytokines. It is known that there is a balance between these two groups of substances in the way that they counteract each other's activity.[<xref rid="ref33" ref-type="bibr">33</xref><xref rid="ref34" ref-type="bibr">34</xref>] So the activation of growth factors theoretically may result in increased rate of bone formation.</p><p>Further studies are needed to detect the biological mechanisms of action of DOX and EM. Evaluation of the bone healing during tooth extraction somewhat mimics that of occurs during osteointegration after implant insertion. Since accelerating bone formation in early stages of bone healing is of great importance specially in the field of implant dentistry, if confirmed in humans, these drugs seems to be useful in oral surgeries involving the bone tissue, such as dental implants, also due to growing interest in the development of dental implant coating drug delivery systems, examining these drugs locally in the implant dentistry in further studies is suggested.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>Due to these findings, it seems that DOX and EM increase new bone formation similarly, and there is no difference between them in induction of bone formation phase in tooth extraction wound. More prolonged researches are needed.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>This study was also supported by the Dental Research Center, Isfahan University of Medical Sciences. The authors would express their gratitude to Dr. M. Manshaei for animal testing and Mrs. F. Mahmoodi for histotechnical aids.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amler</surname><given-names>MH</given-names></name><name><surname>Johnson</surname><given-names>PL</given-names></name><name><surname>Salman</surname><given-names>I</given-names></name></person-group><article-title>Histological and histochemical investigation of human alveolar socket healing in undisturbed extraction wounds</article-title><source>J Am Dent Assoc</source><year>1960</year><volume>61</volume><fpage>32</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">13793201</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devlin</surname><given-names>H</given-names></name><name><surname>Sloan</surname><given-names>P</given-names></name></person-group><article-title>Early bone healing events in the human extraction socket</article-title><source>Int J Oral Maxillofac Surg</source><year>2002</year><volume>31</volume><fpage>641</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12521322</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassetti</surname><given-names>C</given-names></name><name><surname>Kallenberger</surname><given-names>A</given-names></name></person-group><article-title>Influence of chlorhexidine rinsing on the healing of oral mucosa and osseous lesions</article-title><source>J Clin Periodontol</source><year>1980</year><volume>7</volume><fpage>443</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">6938525</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manolagas</surname><given-names>SC</given-names></name></person-group><article-title>Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis</article-title><source>Endocr Rev</source><year>2000</year><volume>21</volume><fpage>115</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">10782361</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>HC</given-names></name></person-group><article-title>The effect of simvastatin on mRNA expression of transforming growth factor-beta1, bone morphogenetic protein-2 and vascular endothelial growth factor in tooth extraction socket</article-title><source>Int J Oral Sci</source><year>2009</year><volume>1</volume><fpage>90</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20687301</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agnihotri</surname><given-names>R</given-names></name><name><surname>Gaur</surname><given-names>S</given-names></name></person-group><article-title>Chemically modified tetracyclines: Novel therapeutic agents in the management of chronic periodontitis</article-title><source>Indian J Pharmacol</source><year>2012</year><volume>44</volume><fpage>161</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22529468</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>SG</given-names></name><name><surname>Still</surname><given-names>K</given-names></name><name><surname>Buttle</surname><given-names>DJ</given-names></name><name><surname>Bishop</surname><given-names>NJ</given-names></name><name><surname>Grabowski</surname><given-names>PS</given-names></name></person-group><article-title>Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors</article-title><source>Bone</source><year>2004</year><volume>35</volume><fpage>471</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15268899</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>S</given-names></name><name><surname>Wakisaka</surname><given-names>A</given-names></name><name><surname>Zeng</surname><given-names>QQ</given-names></name><name><surname>Barnes</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>G</given-names></name><name><surname>Wechter</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats</article-title><source>Bone</source><year>1996</year><volume>19</volume><fpage>637</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">8968031</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golub</surname><given-names>LM</given-names></name><name><surname>Ramamurthy</surname><given-names>NS</given-names></name><name><surname>Kaneko</surname><given-names>H</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Rifkin</surname><given-names>B</given-names></name><name><surname>McNamara</surname><given-names>TF</given-names></name></person-group><article-title>Tetracycline administration prevents diabetes-induced osteopenia in the rat: Initial observations</article-title><source>Res Commun Chem Pathol Pharmacol</source><year>1990</year><volume>68</volume><fpage>27</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">2140619</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bain</surname><given-names>S</given-names></name><name><surname>Ramamurthy</surname><given-names>NS</given-names></name><name><surname>Impeduglia</surname><given-names>T</given-names></name><name><surname>Scolman</surname><given-names>S</given-names></name><name><surname>Golub</surname><given-names>LM</given-names></name><name><surname>Rubin</surname><given-names>C</given-names></name></person-group><article-title>Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats</article-title><source>Bone</source><year>1997</year><volume>21</volume><fpage>147</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">9267690</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoyagi</surname><given-names>M</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Ramamurthy</surname><given-names>NS</given-names></name><name><surname>Golub</surname><given-names>LM</given-names></name></person-group><article-title>Tetracycline/flurbiprofen combination therapy modulates bone remodeling in ovariectomized rats: Preliminary observations</article-title><source>Bone</source><year>1996</year><volume>19</volume><fpage>629</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">8968030</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Ramamurthy</surname><given-names>N</given-names></name><name><surname>Golub</surname><given-names>LM</given-names></name></person-group><article-title>Long-term therapy with a new chemically modified tetracycline (CMT-8) inhibits bone loss in femurs of ovariectomized rats</article-title><source>Adv Dent Res</source><year>1998</year><volume>12</volume><fpage>76</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">9972126</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettany</surname><given-names>JT</given-names></name><name><surname>Peet</surname><given-names>NM</given-names></name><name><surname>Wolowacz</surname><given-names>RG</given-names></name><name><surname>Skerry</surname><given-names>TM</given-names></name><name><surname>Grabowski</surname><given-names>PS</given-names></name></person-group><article-title>Tetracyclines induce apoptosis in osteoclasts</article-title><source>Bone</source><year>2000</year><volume>27</volume><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">10865212</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinkai</surname><given-names>M</given-names></name><name><surname>Henke</surname><given-names>MO</given-names></name><name><surname>Rubin</surname><given-names>BK</given-names></name></person-group><article-title>Macrolide antibiotics as immunomodulatory medications: Proposed mechanisms of action</article-title><source>Pharmacol Ther</source><year>2008</year><volume>117</volume><fpage>393</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">18289694</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giamarellos-Bourboulis</surname><given-names>EJ</given-names></name></person-group><article-title>Macrolides beyond the conventional antimicrobials: A class of potent immunomodulators</article-title><source>Int J Antimicrob Agents</source><year>2008</year><volume>31</volume><fpage>12</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">17935949</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cervin</surname><given-names>A</given-names></name></person-group><article-title>The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis</article-title><source>Acta Otolaryngol</source><year>2001</year><volume>121</volume><fpage>83</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">11270500</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>XH</given-names></name><name><surname>Chen</surname><given-names>BD</given-names></name><name><surname>Wooley</surname><given-names>PH</given-names></name></person-group><article-title>Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity</article-title><source>J Orthop Res</source><year>2004</year><volume>22</volume><fpage>21</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">14656655</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Hawkins</surname><given-names>M</given-names></name><name><surname>Shi</surname><given-names>T</given-names></name><name><surname>Markel</surname><given-names>DC</given-names></name></person-group><article-title>Efficacy of periprosthetic erythromycin delivery for wear debris-induced inflammation and osteolysis</article-title><source>Inflamm Res</source><year>2010</year><volume>59</volume><fpage>1091</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20607583</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buduneli</surname><given-names>E</given-names></name><name><surname>Vardar</surname><given-names>S</given-names></name><name><surname>Buduneli</surname><given-names>N</given-names></name><name><surname>Berdeli</surname><given-names>AH</given-names></name><name><surname>T&#x000fc;rko&#x0011f;lu</surname><given-names>O</given-names></name><name><surname>Ba&#x0015f;kesen</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats</article-title><source>J Periodontol</source><year>2004</year><volume>75</volume><fpage>1516</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">15633329</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joos</surname><given-names>AA</given-names></name></person-group><article-title>Pharmacologic interactions of antibiotics and psychotropic drugs</article-title><source>Psychiatr Prax</source><year>1998</year><volume>25</volume><fpage>57</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">9577846</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>TL</given-names></name><name><surname>Bombonato</surname><given-names>KF</given-names></name><name><surname>Brentegani</surname><given-names>LG</given-names></name></person-group><article-title>Histometric analysis of rat alveolar wound healing</article-title><source>Braz Dent J</source><year>1997</year><volume>8</volume><fpage>9</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">9485631</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elsubeihi</surname><given-names>ES</given-names></name><name><surname>Heersche</surname><given-names>JN</given-names></name></person-group><article-title>Quantitative assessment of post-extraction healing and alveolar ridge remodelling of the mandible in female rats</article-title><source>Arch Oral Biol</source><year>2004</year><volume>49</volume><fpage>401</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">15041488</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iizuka</surname><given-names>T</given-names></name><name><surname>Miller</surname><given-names>SC</given-names></name><name><surname>Marks</surname><given-names>SC</given-names><suffix>Jr</suffix></name></person-group><article-title>Alveolar bone remodeling after tooth extraction in normal and osteopetrotic (ia) rats</article-title><source>J Oral Pathol Med</source><year>1992</year><volume>21</volume><fpage>150</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">1602406</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soory</surname><given-names>M</given-names></name></person-group><article-title>A role for non-antimicrobial actions of tetracyclines in combating oxidative stress in periodontal and metabolic diseases: A literature review</article-title><source>Open Dent J</source><year>2008</year><volume>2</volume><fpage>5</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">19088876</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Manuel</surname><given-names>J</given-names></name><name><surname>Gorczynski</surname><given-names>RM</given-names></name></person-group><article-title>A role for the immunomodulatory molecules CD200 and CD200R in regulating bone formation</article-title><source>Immunol Lett</source><year>2006</year><volume>105</volume><fpage>150</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16530849</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>PS</given-names></name><name><surname>Fernandes</surname><given-names>MH</given-names></name></person-group><article-title>Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells</article-title><source>Arch Oral Biol</source><year>2007</year><volume>52</volume><fpage>251</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17141175</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraz</surname><given-names>MP</given-names></name><name><surname>Mateus</surname><given-names>AY</given-names></name><name><surname>Sousa</surname><given-names>JC</given-names></name><name><surname>Monteiro</surname><given-names>FJ</given-names></name></person-group><article-title>Nanohydroxyapatite microspheres as delivery system for antibiotics: Release kinetics, antimicrobial activity, and interaction with osteoblasts</article-title><source>J Biomed Mater Res A</source><year>2007</year><volume>81</volume><fpage>994</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">17252559</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkan</surname><given-names>A</given-names></name><name><surname>Erdem</surname><given-names>E</given-names></name><name><surname>G&#x000fc;nhan</surname><given-names>O</given-names></name><name><surname>Karasu</surname><given-names>C</given-names></name></person-group><article-title>Histomorphometric evaluation of the effect of doxycycline on the healing of bone defects in experimental diabetes mellitus: A pilot study</article-title><source>J Oral Maxillofac Surg</source><year>2002</year><volume>60</volume><fpage>898</fpage><lpage>904</lpage><pub-id pub-id-type="pmid">12149735</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olmarker</surname><given-names>K</given-names></name></person-group><article-title>Reduction of adhesion formation and promotion of wound healing after laminectomy by pharmacological inhibition of pro-inflammatory cytokines: An experimental study in the rat</article-title><source>Eur Spine J</source><year>2010</year><volume>19</volume><fpage>2117</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">20623241</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname><given-names>GR</given-names></name><name><surname>Torabinejad</surname><given-names>M</given-names></name></person-group><article-title>Effect of systemic doxycycline on alveolar bone loss after periradicular surgery</article-title><source>J Endod</source><year>2000</year><volume>26</volume><fpage>325</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11199747</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mavragani</surname><given-names>M</given-names></name><name><surname>Brudvik</surname><given-names>P</given-names></name><name><surname>Selvig</surname><given-names>KA</given-names></name></person-group><article-title>Orthodontically induced root and alveolar bone resorption: Inhibitory effect of systemic doxycycline administration in rats</article-title><source>Eur J Orthod</source><year>2005</year><volume>27</volume><fpage>215</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">15947219</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamano-Carvalho</surname><given-names>TL</given-names></name></person-group><article-title>Effect of conventional and COX-2 selective non-steroidal anti-inflammatory drugs on bone healing</article-title><source>Acta Ortop Bras</source><year>2007</year><volume>15</volume><fpage>166</fpage><lpage>8</lpage></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugarman</surname><given-names>BJ</given-names></name><name><surname>Lewis</surname><given-names>GD</given-names></name><name><surname>Eessalu</surname><given-names>TE</given-names></name><name><surname>Aggarwal</surname><given-names>BB</given-names></name><name><surname>Shepard</surname><given-names>HM</given-names></name></person-group><article-title>Effects of growth factors on the antiproliferative activity of tumor necrosis factors</article-title><source>Cancer Res</source><year>1987</year><volume>47</volume><fpage>780</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3802082</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waetzig</surname><given-names>GH</given-names></name><name><surname>Rosenstiel</surname><given-names>P</given-names></name><name><surname>Arlt</surname><given-names>A</given-names></name><name><surname>Till</surname><given-names>A</given-names></name><name><surname>Br&#x000e4;utigam</surname><given-names>K</given-names></name><name><surname>Sch&#x000e4;fer</surname><given-names>H</given-names></name><etal/></person-group><article-title>Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1</article-title><source>FASEB J</source><year>2005</year><volume>19</volume><fpage>91</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">15514103</pub-id></element-citation></ref></ref-list></back></article>